These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 3030162

  • 1. Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
    Manrique RV, Manrique V.
    Angiology; 1987 Feb; 38(2 Pt 1):101-8. PubMed ID: 3030162
    [Abstract] [Full Text] [Related]

  • 2. Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP.
    Weithmann KU.
    Gen Pharmacol; 1983 Feb; 14(1):161-2. PubMed ID: 6298055
    [Abstract] [Full Text] [Related]

  • 3. Drug stimulated prostacyclin release.
    Weithmann KU.
    Ric Clin Lab; 1981 Feb; 11 Suppl 1():209-14. PubMed ID: 6324324
    [Abstract] [Full Text] [Related]

  • 4. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
    Mueller HS, Rao PS, Greenberg MA, Buttrick PM, Sussman II, Levite HA, Grose RM, Perez-Davila V, Strain JE, Spaet TH.
    Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
    [Abstract] [Full Text] [Related]

  • 5. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS, Rao PS, Greenberg MA, Buttrick PM, Sussman II, Levite HA, Grose RM, Perez-Davila V, Strain JE, Spaet TH.
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [Abstract] [Full Text] [Related]

  • 6. Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro.
    Weithmann KU, Just M, Schlotte V, Seiffge D.
    Vasa; 1989 Apr; 18(4):273-6. PubMed ID: 2514520
    [Abstract] [Full Text] [Related]

  • 7. The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue.
    Matzky R, Darius H, Schrör K.
    Arzneimittelforschung; 1982 Apr; 32(10):1315-8. PubMed ID: 6817760
    [Abstract] [Full Text] [Related]

  • 8. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K, Löbel P, Steinhagen-Thiessen E.
    Eicosanoids; 1989 Apr; 2(1):39-45. PubMed ID: 2483819
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets.
    Callahan KS, Johnson AR, Campbell WB.
    Circulation; 1985 Jun; 71(6):1237-46. PubMed ID: 2986877
    [Abstract] [Full Text] [Related]

  • 10. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Poggesi L, Scarti L, Boddi M, Masotti G, Serneri GG.
    Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
    [Abstract] [Full Text] [Related]

  • 11. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
    Buttrick PM, Forscher CA, Sussman II, Mueller HS.
    Am Heart J; 1985 Jun; 109(6):1258-63. PubMed ID: 2988323
    [Abstract] [Full Text] [Related]

  • 12. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V, Stemerman M, Schafer A, Adelman B, Smith M, Fuhro R, Salzman E.
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [Abstract] [Full Text] [Related]

  • 13. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA, Kappa JR, Sinha AK, Cottrell ED, Reiser HJ, Addonizio VP.
    J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
    [Abstract] [Full Text] [Related]

  • 14. Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate.
    Vanderwel M, Haslam RJ.
    J Clin Invest; 1985 Jul; 76(1):233-40. PubMed ID: 2991338
    [Abstract] [Full Text] [Related]

  • 15. [Pentoxifylline and prostaglandins].
    Poggesi L, Boddi M, Scarti L, Masotti G.
    Ric Clin Lab; 1988 Jul; 18 Suppl 2():37-46. PubMed ID: 2854659
    [No Abstract] [Full Text] [Related]

  • 16. [Influence of high-voltage electrical burn on the rheological property of platelet and leukocyte in rats and the interventional effect of pentoxifylline].
    Zhang QF, Wei W, Shang T, Zhou HM, Li ZN, Wang CJ, Feng JK, Xu SJ, Cui DS.
    Zhonghua Shao Shang Za Zhi; 2012 Dec; 28(6):428-34. PubMed ID: 23327912
    [Abstract] [Full Text] [Related]

  • 17. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A, Stierle A, Anton R, Cazenave JP.
    Biochem Pharmacol; 1982 Nov 15; 31(22):3597-600. PubMed ID: 6295405
    [Abstract] [Full Text] [Related]

  • 18. Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma.
    Dembinska-Kiec A, Rücker W, Schönhöfer PS, Gandolfi C.
    Thromb Haemost; 1979 Dec 21; 42(4):1340-3. PubMed ID: 232318
    [No Abstract] [Full Text] [Related]

  • 19. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB, Miller OV, Spillers C, Gorman RR.
    Prostaglandins; 1983 Aug 21; 26(2):287-302. PubMed ID: 6316420
    [Abstract] [Full Text] [Related]

  • 20. Influence of pentoxifylline administered in vivo on the synthesis of PGI2 in human varicose veins.
    Fahr A, Langer R, Sziegoleit W, Albert H, Liebal H, Mest HJ.
    Biomed Biochim Acta; 1988 Aug 21; 47(10-11):S238-40. PubMed ID: 3073763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.